Telehealth is about to get psychedelic.
That is the idea behind Mindleap, which bills itself as the first psychedelics-focused digital telehealth platform, as well as “the only digital health platform that combines telehealth with mood, emotion and habit tracking.”
Users of the platform will have the ability to “browse vetted and experienced specialists and easily schedule appointments and purchase mental health services,” while specialists who use the platform “benefit from the platform’s full freedom to manage their virtual practice on their terms setting their own prices, choosing the hours they work each week,” a press release boasted.
Trust Is Key
The company says that it “will never sell or license user data, including electronic Personal Health Information (ePHI) to anyone,” while asserting that it maintains “strict policies around how data is handled and stored; all data is encrypted in-transit and at-rest, and specialists are not permitted to save their clients’ data – they can only view it temporarily while the user chooses to share it during a video call.”
The platform is said to “meet all HIPAA guidelines by implementing secure electronic access to health data and remains in compliance with privacy regulations and best practices.”
“Mindleap was designed with